| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.55M | 4.86M | 2.31M | 2.71M | 2.68M | 2.35M |
| Gross Profit | 5.37M | 4.27M | 2.31M | 2.53M | 2.68M | 2.35M |
| EBITDA | 1.97M | 1.82M | 428.00K | 919.00K | -256.00K | 1.72M |
| Net Income | 1.06M | 984.00K | 84.00K | 485.00K | -334.00K | 1.26M |
Balance Sheet | ||||||
| Total Assets | 14.11M | 15.47M | 8.59M | 8.96M | 9.02M | 4.44M |
| Cash, Cash Equivalents and Short-Term Investments | 2.24M | 2.68M | 2.63M | 4.58M | 4.72M | 609.00K |
| Total Debt | 1.97M | 2.99M | 371.00K | 311.00K | 385.00K | 1.49M |
| Total Liabilities | 3.87M | 5.46M | 1.00M | 1.06M | 1.03M | 2.22M |
| Stockholders Equity | 10.24M | 10.02M | 7.59M | 7.89M | 7.99M | 2.21M |
Cash Flow | ||||||
| Free Cash Flow | 1.20M | 1.35M | -206.00K | 1.10M | 897.00K | 795.00K |
| Operating Cash Flow | 1.25M | 1.41M | -156.00K | 1.15M | 934.00K | 811.00K |
| Investing Cash Flow | -3.57M | -3.58M | -1.23M | -43.00K | -37.00K | -16.00K |
| Financing Cash Flow | 2.29M | 2.22M | -566.00K | -1.24M | 3.22M | -528.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | £11.31M | 25.58 | 11.90% | 5.12% | 186.12% | 294.83% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | £280.23M | -0.96 | -12.22% | 15.28% | -3.91% | -310.36% | |
60 Neutral | £143.09M | -138.94 | 1.15% | 2.75% | 8.01% | -23.02% | |
54 Neutral | £327.84M | 275.23 | 0.58% | 2.31% | 6.90% | 145.00% | |
41 Neutral | £320.89M | -2.81 | -142.88% | ― | -4.87% | ― |